|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.03.26 - 17:48
|
Generational Group Advises Rapid Electroplating Process, Inc. in its Sale to B & B Electroplating Co., Inc. (Business Wire)
|
|
|
DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Rapid Electroplating Process, Inc. to B & B Electroplating Co., Inc. The acquisition closed March 16, 2026.
Based in Melrose Park, Illinois, Rapid Electroplating Process, Inc. is a long-established manufacturer of portable electroplating equipment and supplies, serving both government and industrial clients for more than 85 years. Offering complete plating systems, components, and chemicals, the company specializes in simple, reliable solutions for applying, repairing, and restoring metal plating in both shop and field environments. Known for its user-friendly technology and dual-source plating capabilities, Rapid Electroplating enables fast, high-quality results across a wide range of metals, including gold, silver, nickel, and copper. They continue to build on decades of expertise by providing practical, efficient plating solutions tailored to di...
|
|
|
17.03.26 - 21:21
|
Imperative Care Announces $100 Million Financing (Business Wire)
|
|
|
Funding supports continued growth and innovation in thromboembolic disease careCAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc., a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the closing of an oversubscribed $100 million convertible note financing.
The round was co-led by new investors Elevage Medical Technologies and Perceptive Advisors in partnership with existing investor Catalio Capital Management, LP. New investors Longaeva Partners LP and Brown Advisory also participated in the financing. The round was supported by Imperative Care's existing investors, including Ally Bridge Group and Bain Capital Life Sciences.
Imperative Care also announced the appointment of Evan Melrose, M.D., CEO of Elevage Medical Technologies, to its Board of Directors. A seasoned medtech investor and health care innovator, Dr. Melrose brings extensive experience built over decades identifying and supporting category‑defining medical ...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
